Biopharma IPR Trends - Mid-Year Update 2019
Oona Johnstone and Andrew William's article, titled "Biopharma IPR Trends - 2019 Mid-Year Update," appeared in the April issue of Life Science Leader. Read more.
Oona Johnstone and Andrew William's article, titled "Biopharma IPR Trends - 2019 Mid-Year Update," appeared in the April issue of Life Science Leader. Read more.
An article written by Hunter Baker titled, "Playing for Time" was featured in Mewburn Ellis Forward Magazine.
In the wake of SAS Institute v. Iancu, the PTAB has sometimes expanded pending IPRs to include previously un-instituted grounds. But can the PTAB rely on SAS to retroactively deny institution? A recen...
(as published by DesignNews) When considering intellectual property protection, businesses often overlook the value of design patents and trade dress rights. Products may have ornamentation and/or vis...
(as published by business.com) In most situations, a patent is the only way to deter a competitor from taking and using a company’s innovations. However, there are many aspects of patent law that are ...
Jonathan Roses was the lead author on behalf of the Boston Patent Law Association's (BPLA’s) Patent Office Practice Committee of a December 2018 Response to USPTO Request for Comments on motion to ame...
(as published by IPWatchdog) Developing the right strategy for protecting intellectual property is vital to any starting company. Equally important is revisiting your approach as the company grows and...
Adam Zeiger's article titled “Who is the Inventor? The Art of Determining Conception of an Idea” was published by Medical Device and Diagnostic Industry (MD+DI). Read more.
(As published in IP Watchdog) Inventions that are worth protecting are at the core of almost every new technology startup. For a newly formed company, it can be daunting to evaluate the amount of time...
The Federal Circuit recently held in In Re Maatita that a single plan-view drawing in a design patent application for a shoe bottom sufficiently enabled the claimed design, and the lack of additional ...
Jonathan Roses co-authored on behalf of the Boston Patent Law Association's (BPLA’s) Patent Office Practice Committee an August 2018 Response to USPTO Request for Comments on changes in examination pr...
Typically, the PTAB and district courts apply different claim construction standards, which can cause the two forums to construe the same term from the same patent differently. Such divergent treatmen...